Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Oral administration is the most commonly used and readily accepted form of drug delivery; however, it is find that many drugs are difficult to attain enough bioavailability when administered via this route. Polymeric micelles (PMs) can overcome some limitations of the oral delivery acting as carriers able to enhance drug absorption, by providing (1) protection of the loaded drug from the harsh environment of the GI tract, (2) release of the drug in a controlled manner at target sites, (3) prolongation of the residence time in the gut by mucoadhesion, and (4) inhibition of efflux pumps to improve the drug accumulation. To explain the mechanisms for enhancement of oral bioavailability, we discussed the special stability of PMs, the controlled release properties of pH-sensitive PMs, the prolongation of residence time with mucoadhesive PMs, and the P-gp inhibitors commonly used in PMs, respectively. The primary purpose of this paper is to illustrate the potential of PMs for delivery of poorly water-soluble drugs with bioavailability being well maintained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of the mechanisms involved in the absorption of exogenous drugs in the small intestine. (a) Transcellular transport; (b) active transport; (c) facilitated diffusion; (d) receptor-mediated endocytosis; (e) paracellular transport; (f) pinocytosis [3].](https://figures.cochat.ai/paper-figures/f760f35972f34f1c8e324112b058d11c/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-1.jpg)


![Figure 4 Pluronic block copolymers available from BASF (Wyandotte, MI, USA) contain two hydrophilic EO blocks and a hydrophobic PO block [167].](https://figures.cochat.ai/paper-figures/292163f5bd3e4a15b3eb9e18032f118f/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985 · cited 3×
“Pgp is a 170-kDa membrane transporter which is part of the ATP-binding cassette (ABC) [150].”
BackgroundSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“Besides, approximately 40% of currently marketed immediate-release oral drugs are considered practically insoluble (solubility less than 100 μg/mL) in water [6, 7].”
BackgroundImpact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348 · cited 2×
“macromolecules [12, 13].”
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155 · cited 2×
“Blends of this polymer with polyethylacrylate (PMAA-PEA) and polymethacrylate (PMAA-PMA) can be tailored to dissolve in specific pH ranges corresponding to specific locations in the GI tract [100–102].”
BackgroundMicellization of block copolymers
Riess, G. (2003) · Progress in Polymer Science · doi:10.1016/s0079-6700(03)00015-7 · Cited by 1,953 · cited 1×
“PMs are self-assembled core-shell nanostructures formed in an aqueous solution consisting of amphiphilic block copolymers (see Figure 2) [35, 36].”
BackgroundMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 1×
“Mucoadhesion can be obtained by the building of either nonspecific interactions with the mucosal surface, such as covalent bonds, ionic bonds, hydrogen bonding, and van der Waals’ interactions [117], or specific interactions by functionalizing polymers with targeting ligands (e.”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623 · cited 1×
“Intrinsic properties of drugs such as poor stability in the gastric environment, lowmucosal permeability, and low solubility in the mucosal fluids will contribute to low absorption [26, 27].”
BackgroundPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 3×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundMethodCone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459 · cited 1×
“The luminal surface of mucosal tissues is protected by a highly viscoelastic layer [110], and the protective coatings rapidly remove foreign particles from the GI tract which probably lead to low bioavailability.”
Background
Research works printed but not linked: 2
- Lee ES Shin HJ Na K Bae YH Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization Journal of Controlled Release 2003 90 3 363 374 2-s2.0-0038106270 12880703 · DOI · Paper page
- Mo R Jin X Li N The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles Biomaterials 2011 32 20 4609 4620 2-s2.0-79955522520 21440934 · DOI · Paper page
Cited by
Items 201–300 of 620
Nogami, S., Uchiyama, H., Kadota, K., & Tozuka, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120047 · Cited by 27
Sabbagh, F. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00257 · Cited by 26
Nanocarrier-mediated co-delivery systems for lung cancer therapy: recent developments and prospects
Farooq, M. A., Aquib, M., Khan, D. H., Ghayas, S., Ahsan, A., Ijaz, M., Banerjee, P., Khan, M. A., Ahmad, M. M., & Wang, B. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-019-00897-7 · Cited by 26
“They can penetrate easily into tumor tissue due to their nanosize in contrast to other nanoparticles (Xu et al. 2013;Yokoyama 2011).”
BackgroundDevelopment of chitosan based β-carotene mucoadhesive formulation for skin cancer treatment
Azhar, F., Naureen, H., Shahnaz, G., Hamdani, S. D. A., Kiani, M. H., Khattak, S., Manna, M. K., Babar, M. M., Rajadas, J., Rahdar, A., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126659 · Cited by 29
“Polymeric micelles (PMs) are a type of nanostructures spontaneously generated through self-aggregation of polymeric amphi-philic components at concentrations higher than the critical micellar concentration [50].”
Tariq, M., Alam, A., Singh, A. T., Panda, A. K., & Talegaonkar, S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.054 · Cited by 27
“Group 1 was kept as control i.e. inoculated with EPI-MNPs however no prior treatment with any agent was given and their uptake was assumed 100% (Xu et al., 2013; Yuan et al., 2013), second group 2 was pre-treated with 25 µM sodium azide for 1h at 37 ˚C then with EPI-MNPs (Zhang et al., 2011), prior…”
MethodAdvancement in pulmonary drug delivery systems for treatment of tuberculosis
Goyal, A. K., Garg, T., Bhandari, S., & Rath, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00022-1 · Cited by 30
Yu, A.-A., Lv, J., Yuan, F., Xia, Z., Fan, K., Chen, G., Ren, J.-L., Lin, C., Wei, S., & Yang, F. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s145488 · Cited by 26
“The hypothesis that inhibition of P-gp improved the bioavailability of drugs, which were the substrates of this efflux transporter, has gained widespread recognition.(25,27) The results indicated that intranasal administration of LTG-loaded mPEG-PLA/ TPGS mixed micelles might serve as a promising drug delivery system…”
García, M. C., Aloisio, C., Onnainty, R., & Ullio-Gamboa, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100716-7.00003-9 · Cited by 43
A pretargeting nanoplatform for imaging and enhancing anti-inflammatory drug delivery
Khang, M. K., Zhou, J., Co, C. M., Li, S., & Tang, L. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.06.019 · Cited by 26
Dhanjal, D. S., Sharma, P., Mehta, M., Tambuwala, M. M., Prasher, P., Paudel, K. R., Liu, G., Shukla, S. D., Hansbro, P. M., Chellappan, D. K., et al. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0081 · Cited by 28
“Today, the polymeric micelles are being used for personalized treatment, and this approach has gained significant attention for its application in targeted drug delivery [164,165].”
BackgroundSu, W., Xu, W., Liu, E., Su, W., & Polyakov, N. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087652 · Cited by 26
“In summary, micelles can respond to external or internal stimuli and thus play a role in stabilizing, targeting or controlling the release of drugs [68,69], which are ideal drug delivery systems for the treatment of central nervous system diseases, particularly AD, due to their excellent ability to penetrate the blood…”
BackgroundSelf-citationSelf-assembled block copolymer biomaterials for oral delivery of protein therapeutics
Chapa-Villarreal, F. A., Miller, M., Rodriguez‐Cruz, J. J., Pérez-Carlos, D., & Peppas, N. A. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122191 · Cited by 25
Hartlieb, M., Pretzel, D., Wagner, M., Hoeppener, S., Bellstedt, P., Görlach, M., Englert, C., Kempe, K., & Schubert, U. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02069c · Cited by 25
Polymeric nanomicelles for sustained delivery of anti-cancer drugs
Jeetah, R., Bhaw‐Luximon, A., & Jhurry, D. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.04.009 · Cited by 26
“International Journal of Nanomedicine , 8, 3309–3319, 2013 [6] Xu W, Ling P, Zhang T.”
BackgroundMolecular Dynamics Simulations to Study Drug Delivery Systems
Albano, J. M. R., de Paula, E., & Pickholz, M. (2018) · InTech eBooks · doi:10.5772/intechopen.75748 · Cited by 28
Drug Micro-Carriers Based on Polymers and Their Sterilization
da Costa, R. C., Pereira, E. D., Machado, F., de Jesus, E. O., & de Souza, F. G. (2018) · Chemistry & Chemical Technology · doi:10.23939/chcht12.04.473 · Cited by 26
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach
Mangla, B., Neupane, Y. R., Singh, A., & Kohli, K. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109379 · Cited by 24
“The potential drug-drug interactions between various combinatorial therapeutic regimen of anticancer drugs would fruitfully avoided by utilization of lipid nanocarrier-based approach where drugs are encapsulated within carrier matrices and also prevent from degradation in the GIT, enhanced absorption and enhanced oral…”
BackgroundCarbohydrate anchored lipid nanoparticles
Kakade, P., Chatterjee, A., Pandya, A., Disouza, J., & Patravale, V. B. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121681 · Cited by 25
Ortega, M. A., León-Oliva, D. D., Boaru, D. L., Fraile‐Μartinez, O., Montero, C. G., Díaz, R., Coca, S., Barrena-Blázquez, S., Buján, J., García‐Honduvilla, N., et al. (2023) · Gels · doi:10.3390/gels9080617 · Cited by 24
Ahmad, A., Ahmad, A., Sudhakar, R., Varshney, H., Subbarao, N., Ansari, S., Rauf, A., & Khan, A. U. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1255260 · Cited by 24
Highly stable photosensitive supramolecular micelles for tunable, efficient controlled drug release
Gebeyehu, B. T., Lee, A.-W., Huang, S.-Y., Muhabie, A. A., Lai, J., Lee, D., & Cheng, C. (2018) · European Polymer Journal · doi:10.1016/j.eurpolymj.2018.12.005 · Cited by 24
Drug-delivery nanocarriers for skin wound-healing applications
Medina-Cruz, D., Saleh, B., Vernet-Crua, A., Ajó, A., Roy, A. K., & Webster, T. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816413-6.00022-8 · Cited by 32
Trani, N. D., Liu, H., Qi, R., Viswanath, D. I., Liu, X., Chua, C. Y. X., & Grattoni, A. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102417 · Cited by 23
Summer, M., Hussain, T., Ali, S., Khan, R. R. M., Muhammad, G., & Liaqat, I. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2375337 · Cited by 27
“Because their internal core structure allows for the assimilation of this type of medicine, these nanostructures have a significant potential for hydrophobic drug delivery, which will improve stability and accessibility [72,73] .”
Role of polymer–drug conjugates in organ-specific delivery systems
Paramjot, Khan, N. M., Kapahi, H., Kumar, S., Bhardwaj, T., Arora, S., & Mishra, N. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1016436 · Cited by 26
Tima, S., Okonogi, S., Ampasavate, C., Pickens, C. J., Berkland, C. J., & Anuchapreeda, S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.09.010 · Cited by 23
Fellin, C. R., & Nelson, A. (2022) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c01538 · Cited by 22
Zhou, Y. H., Wang, C., Liu, W., Yang, M., Xu, B., & Chen, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050889 · Cited by 22
“Therefore, they have been widely investigated o enhance dissolution rates and oral bioavailability of poorly wat r-solubl drugs [11].”
BackgroundAnuța, V., Talianu, M.-T., Dinu‐Pîrvu, C., Ghica, M. V., Prisada, R. M., Kaya, M. G. A., & Popa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147520 · Cited by 26
Chitosan Functionalized Skin-Adhesive Formulation for Ergotamine Delivery in Melanoma Treatment
Azhar, F., Naureen, H., Shahnaz, G., Hamdani, S. D. A., Shareef, U., Khattak, S., Babar, M. M., Rahdar, A., Fathi‐karkan, S., & Pandey, S. (2024) · BioNanoScience · doi:10.1007/s12668-024-01638-z · Cited by 23
“Skin-adhesive properties of the formulation further prolong its residence time at the site of delivery thus enhancing the permeation of the drug [32].”
Biomaterials-Based Vaccination Strategies for the Induction of CD8+T Cell Responses
Chesson, C. B., Ekpo-Otu, S., Endsley, J. J., & Rudra, J. S. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00412 · Cited by 22
Lajous, H., Riva, R., Lelièvre, B., Tétaud, C., Avril, S., Hindré, F., Boury, F., Jérôme, C., Lecomte, P., & Garcion, E. (2018) · Biomaterials Science · doi:10.1039/c8bm00346g · Cited by 23
He, C., Jin, Y., Deng, Y., Zou, Y., Han, S., Zhou, C., Zhou, Y., & Liu, Y. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00020 · Cited by 22
Mixed micelles formulation for carvedilol delivery: In-vitro characterization and in-vivo evaluation
Öztürk, K., Arslan, F. B., Öztürk, S. C., & Çalış, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121294 · Cited by 22
Singh, M. B., Raghav, S., Chavda, V., Singh, P., Yadav, S. K., Kim, W., & Jain, P. (2026) · Nano Trends · doi:10.1016/j.nwnano.2026.100183 · Cited by 22
Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease
Liang, X., Wen, K., Chen, Y., Fang, G., Yang, S., & Li, Q. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s378073 · Cited by 21
“Oral administration has the advantages of convenience, simplicity, minimal pain and high applicability, especially for the treatment of chronic diseases.(21) Meanwhile, it is expected to solve the non-compliance problem of protein and peptide molecules during the injection.”
BackgroundSmart drug delivery nanostructured systems for cancer therapy
Mahfuz, A. M. U. B., Hossain, M. K., Khan, M. I., Hossain, I., & Anik, M. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85671-3.00001-4 · Cited by 26
Luhar, M., Viradiya, R. A., Panjabi, S. H., & Patel, G. C. (2025) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2024.0060 · Cited by 25
“30,31 Nanomicelles manifest as surfactant micelles, formed by surfactants, and polymeric micelles, formed by copolymers.”
Curia, S., & Howdle, S. M. (2016) · Polymer Chemistry · doi:10.1039/c6py00066e · Cited by 21
Mukhija, A., & Kishore, N. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.10.044 · Cited by 21
Kunjiappan, S., Theivendren, P., Prasad, P., Sukumaran, S., Somasundaram, B., Murugesan, S., Murugan, I., & Pavadai, P. (2018) · Biomedical Materials · doi:10.1088/1748-605x/aabcea · Cited by 22
Advanced colloidal technologies for the enhanced bioavailability of drugs
Din, F. U., Saleem, S., Aleem, F., Ahmed, R., Huda, N. U., Ahmed, S., Khaleeq, N., Shah, K. U., Ullah, I., Zeb, A., et al. (2018) · Cogent Medicine · doi:10.1080/2331205x.2018.1480572 · Cited by 21
Polyhydroxyalkanoates Applications in Drug Carriers
Papaneophytou, C. P., Katsipis, G., Halevas, E. G., & Pantazaki, Α. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-3759-8_5 · Cited by 24
Polymeric nanocarriers for cancer theranostics
Vijayan, V. M., & Muthu, J. (2017) · Polymers for Advanced Technologies · doi:10.1002/pat.4070 · Cited by 22
Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review
Espinosa, J. L., Park, P., Holcomb, M., Godin, B., & Villapol, S. (2024) · Therapeutic Delivery · doi:10.1080/20415990.2024.2401307 · Cited by 23
Rehan, F., Karim, M. E., Ahemad, N., Shaikh, M. F., Gupta, M., Gan, S. H., & Chowdhury, E. H. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00595-7 · Cited by 20
Chen, Z.-H., Du, D., Fu, Y.-F., Wu, J., Guo, D., Li, Y., Chen, M.-N., Yuan, Z., Zhang, K., Zhang, Z., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100747 · Cited by 25
Lamey, C. A., Moussa, N., Helmy, M. W., Haroun, M., & Sabra, S. A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104807 · Cited by 20
Insights into the innovative approaches in fiber technology for drug delivery and pharmaceuticals
Wal, P., Wal, A., Saxena, B., Mishra, S., Elossaily, G. M., Arora, R., Singh, C., Sachdeva, M., Anwer, M. K., Gulati, M., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104877 · Cited by 22
Laffleur, F., & Mayer, A. H. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2289586 · Cited by 21
“Due to its many advantages like ‘stealth’ properties, PEG is commonly used as outer-shell forming polymer, alternatively poly(N-vinyl-2-pyrrolidone) (PVP) or poly(acrylic acid) (PAA) [42,43].”
BackgroundMethodCombretastatin A4-camptothecin micelles as combination therapy for effective anticancer activity
Assali, M., Kittana, N., Alhaj-Qasem, S., Adas, R., Saleh, D., Arar, A., & Zohud, O. (2019) · RSC Advances · doi:10.1039/c8ra08794f · Cited by 20
Cationic micelles as nanocarriers for enhancing intra-cartilage drug penetration and retention
Zhu, C., Zhang, Z., Wen, Y., Song, X., Zhu, J., Yao, Y., & Li, J. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb02050e · Cited by 20
Nanoscience in Targeted Brain Drug Delivery
Çetin, M., Aytekin, E., Yavuz, B., & Pehlivan, S. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803796-6.00007-1 · Cited by 27
Progress in Polymeric Micelles as Viable Wagons for Brain Targeting
Parashar, P., Kanoujia, J., & Kishore, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221223101753 · Cited by 21
Akash, S., Mir, S. A., Mahmood, S., Hossain, S., Islam, M. R., Mukerjee, N., Nayak, B., Nafidi, H., Jardan, Y. A. B., Mekonnen, A. B., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1206816 · Cited by 19
“Drug absorption depends on water solubility; a higher water-soluble compound implies higher absorption properties and ample bioavailability (Xu et al., 2013).”
BackgroundSharma, A., Jangra, N., Dheer, D., Jha, S. K., Gupta, G., Puri, V., & Kesharwani, P. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.113338 · Cited by 21
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment
Gaweł, A. M., Bętkowska, A., Gajda, E., Godlewska, M., & Gaweł, D. (2024) · Biomedicines · doi:10.3390/biomedicines12081822 · Cited by 20
“Micelles have been found to be a safe and effective method of inducing an anti-glioma effect and prolonging the survival of xenograft rats or mice via various routes of administration, including intranasal, oral, and intravenous [165–167].”
MethodSupramolecularly self-assembled nano-twin drug for reversing multidrug resistance
Wu, C., Li, X., Shi, L., Gao, X., Li, J., Zhu, X., & Zhang, C. (2018) · Biomaterials Science · doi:10.1039/c8bm00437d · Cited by 20
Characterization of PMMA-b-PDMAEMA aggregates in aqueous solutions
Saraiva, G. K. V., de Souza, V. V., de Oliveira, L. C., Noronha, M. L. C., Masini, J. C., Chaimovich, H., Salinas, R. K., Florenzáno, F., & Cuccovia, I. M. (2019) · Colloid & Polymer Science · doi:10.1007/s00396-019-04482-w · Cited by 19
“Aggregation of polymers with polar block excess leads to micelle-like aggregates, known as polymeric micelles [4, 5].”
BackgroundMadbouly, N. A., Nashee, H., Elgendy, A. A., Rabee, I., & Amir, A. E. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.4.550 · Cited by 23
“Nanoparticles have become highly attractive for their applications in the fields of medicine and biology in the last few years [5].”
BackgroundArafa, W. M., Elkomy, M. H., Aboud, H. M., ALI, M. I., Gawad, S. S. A., Aboelhadid, S. M., Mahdi, E. A., Alsalahat, I., & Abdel-Tawab, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102023 · Cited by 19
“Such results are endorsed with prior literature arts [20,47,48].”
BackgroundResultNanocarriers for gene delivery to the cardiovascular system
Shi, L.-X., Liu, X.-R., Zhou, L.-Y., Zhu, Z., Yuan, Q., & Zou, T. (2023) · Biomaterials Science · doi:10.1039/d3bm01275a · Cited by 20
Puranik, P. K., Chainani, Y. D., & Hussain, U. (2025) · Next research. · doi:10.1016/j.nexres.2025.100234 · Cited by 18
Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS
Gagliardi, M., & Borri, C. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161027111542 · Cited by 19
Abraham-Miranda, J., Garnero, C., Zoppi, A., Sterren, V. B., Ayala, A. P., & Longhi, M. R. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.10.038 · Cited by 18
Abbot, V., & Sharma, P. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.01.274 · Cited by 18
Falese, B. A., Kolawole, A. N., Sarumi, O. A., & Kolawole, A. O. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116346 · Cited by 18
Micellar Antibiotics of Bacillus
Ferreira, W. T., Hong, H. A., Hess, M., Adams, J. R. G., Wood, H., Bakun, K., Tan, S., Baccigalupi, L., Ferrari, E., Brisson, A. R., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081296 · Cited by 19
“Polymeric micelles have been shown to enhance the bioavailability of drugs by increasing solubility [36], and so the effect shown here illustrates the potential of Bacillus lipopeptides to increase solubility and, therefore, the bioavailability of hydrophobic antimicrobials, including resveratrol.”
BackgroundSharifyrad, M., Gohari, S., Fathi, M., Danafar, H., Hosseini, M., Mostafavi, H., & Manjili, H. K. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103378 · Cited by 18
Chella, N., & Tadikonda, R. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.911308 · Cited by 18
“Tadikonda Drug Dev Ind Pharm, 2015; 41(6): 888–897”
Kapishon, V., Allison‐Logan, S., Whitney, R. A., Cunningham, M. F., Szewczuk, M. R., & Neufeld, R. J. (2016) · Biomaterials Science · doi:10.1039/c5bm00519a · Cited by 18
Rahmani, A., Mousavi, H. Z., Salehi, R., & Bagheri, A. (2020) · RSC Advances · doi:10.1039/d0ra03467c · Cited by 18
Mittal, G. C., Prashanth, A., Dhali, A., Prasad, R., Subramanian, Y., Nurani, K. M., & Găman, M. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i18.105836 · Cited by 20
“…micelles for enhanced solubility and controlled release: Polymeric micelles are amphiphilic block copolymers[53] that increase the solubility and stability of insoluble plant extracts[54,55] against hydrophobic environments and are linked to higher therapeutic efficacy in liver treatments[56,57].”
Medicinal cannabis pharmacokinetics and potential methods of delivery
Kebede, L., Dezfooli, S. M., & Seyfoddin, A. (2022) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2022.2035748 · Cited by 18
Multicomponent-Loaded Vesosomal Drug Carrier for Controlled and Sustained Compound Release
Lee, D., Song, S., Kim, S., Lee, M., Kim, E., Yoon, S., Kim, H., Son, S., Jung, H. S., Huh, Y. S., et al. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00528 · Cited by 17
Italiya, K. S., Basak, M., Mazumdar, S., Sahel, D. K., Shrivastava, R., Chitkara, D., & Mittal, A. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00833 · Cited by 17
Uchegbu, I. F., Breznikar, J., Zaffalon, A., Odunze, U., & Schätzlein, A. G. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050744 · Cited by 17
Wang, Y., Wang, X., Lv, Y., Guo, Y., He, M., Lan, M., Zhao, Y., & Gao, F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121125 · Cited by 17
Zancan, L. R., Bruinsmann, F. A., Paese, K., Türck, P., Bahr, A. C., Zimmer, A., Carraro, C. C., Schenkel, P. C., Belló‐Klein, A., Schwertz, C. I., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121181 · Cited by 17
Solubility enhancement and drug release mechanism of polymeric micelles
Kenguva, G., Rout, S. R., Fatima, M., Dubey, S. K., Alexander, A., Abourehab, M. A. S., Kesharwani, P., & Dandela, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00006-9 · Cited by 18
Nanocellulose and Nanogels as Modern Drug Delivery Systems
Moscovici, M., Hlevca, C., Căşărică, A., & Pavaloiu, R. (2017) · Wiley eBooks · doi:10.1002/9783527803835.ch9 · Cited by 23
Tenoxicam-loaded polymeric micelles material: Formulation, optimization, and evaluation
Hussein, H. A., & Maraie, N. K. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.08.218 · Cited by 16
Herbal bioactive–based nano drug delivery systems
Sohail, M., Rabbi, F., Younas, A., Hussain, A., Yu, B., Li, Y., Iqbal, S., Ullah, K. H., Qadeer, A., Aquib, M., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824385-5.00011-x · Cited by 16
Ye, Y., Zhang, T., Li, W., Sun, H., Lu, D., Wu, B., & Zhang, X. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1827-7 · Cited by 16
“as nanosuspensions (1) , l ipid nanopartic les (2) , microemulsions (3), micelles (4), and polymeric nanoparticles (5).”
Self-citationMohanty, S., Tirkey, B., Jena, S. R., Samanta, L., & Subuddhi, U. (2023) · Langmuir · doi:10.1021/acs.langmuir.2c02797 · Cited by 16
Khongkow, M., Rimsueb, N., Jantimaporn, A., Janyaphisan, T., Woraprayote, W., Visessanguan, W., & Ruktanonchai, U. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102470 · Cited by 16
Saenjaiban, A., Thanakkasaranee, S., Jantanasakulwong, K., Punyodom, W., Lee, Y. S., Singjai, P., Reungsang, A., Tanadchangsaeng, N., Worajittiphon, P., Panyathip, R., et al. (2024) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2024.115658 · Cited by 15
Kim, Y. B., Lee, S., Kasala, D., Zhao, Y., Jiao, A., Hong, J., Kim, J. S., Yoon, A. R., & Yun, C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113711 · Cited by 16
Formulation and optimization for DPP-4 inhibitor nanomicelles using response surface methodology
Sharma, D., Bhargava, S., & Kumar, B. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1701003 · Cited by 15
“Polymeric nanomicelles (PNM) is among the best approaches for enhancing the permeability, bioavailability of peptides and therapeutic drugs, sustaining drug levels, reducing systemic side effects and to increase drug accumulation in the targeted site [4].”
BackgroundSalmanpour, M., Yousefi, G., Mohammadi‐Samani, S., Abedanzadeh, M., & Tamaddon, A. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101933 · Cited by 15
Ahmadi, M., Siavashy, S., Ayyoubzadeh, S. M., Keçili, R., & Ghorbani‐Bidkorbeh, F. (2021) · PubMed Central · doi:10.22037/ijpr.2021.114226.14769 · Cited by 17
Altınkök, Ç., Acik, G., Karabulut, H. R. F., Çiftçi, M., Taşdelen, M. A., & Dağ, A. (2021) · Polymers for Advanced Technologies · doi:10.1002/pat.5478 · Cited by 17
Na, H. S., Woo, J. S., Kim, J. H., Lee, J. S., Um, I. G., Cho, K.-H., Kim, G. H., Cho, M., Chung, S. J., & Park, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270351 · Cited by 16
Formulation design space for stable, pH sensitive crystalline nifedipine nanoparticles
Jog, R., Unachukwu, K., & Burgess, D. J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.039 · Cited by 15
Nanocarriers for protein and peptide delivery: Recent advances and progress
-, S. S. V. S. B. B. (2021) · Journal of Research in Pharmacy · doi:10.29228/jrp.1 · Cited by 20
“Poorly water-soluble drugs are easily solubilized in the internal core of micelles due to their hydrophobic environment [59].”
BackgroundA Comprehensive Review of Solubility Enhancement Techniques for Poorly Soluble Drugs
Saripilli, R., & Sharma, D. K. (2025) · Journal of Solution Chemistry · doi:10.1007/s10953-025-01502-y · Cited by 14
“PMs may manipulate the drug molecules to reach the absorption window or target site by coupling various types of polymers at the hydrophilic end by various functional groups of the copolymer, like receptor-sensitive and pH-sensitive groups [137, 138].”
Self-assembling smart materials for biomaterials applications
Rajapaksha, R. D. A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-103013-4.00007-8 · Cited by 19
Pradhan, S. P., Sahu, P. K., & Behera, A. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04696-1 · Cited by 14
“Polymeric micelles are nanostructured core–shell-type formulations comprised of amphiphilic block copolymers, which effectively increase drug bioavailability, stability, and target specificity, and protect the drug interaction with non-target cells and amino acids [199, 200].”
BackgroundPolymeric Micelles in Targeted Breast Cancer Therapy:Recent Advances and Future Trends
Soni, A., & Jaiswal, V. P. (2025) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2025.9290122 · Cited by 14
Polymeric Nanowires for Diagnostic Applications
Hubbe, H., Mendes, E., & Boukany, P. E. (2019) · Micromachines · doi:10.3390/mi10040225 · Cited by 14
Metadata
- Authors
- Xu, W., Ling, P., & Zhang, T.
- Affiliations
- Shandong University (CN)
- Institute of Biopharmaceuticals of Shandong Province, Jinan 250101, China
- Corresponding author
- Ling, Peixue
- ORCID
- Venue
- Journal of Drug Delivery
- Publisher
- Wiley
- Published
- 2013-06-27
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 2090-3014 (ISSN-L)
- 2090-3022
- PMC
- PMC3712247
- OpenAlex
- W2061955697
- Cited by
- 595
- References
- 181
- Citations by year
- 2026: 32 · 2025: 47 · 2024: 50 · 2023: 60 · 2022: 74 · 2021: 70 · 2020: 56 · 2019: 49 · 2018: 41 · 2017: 43 · 2016: 32 · 2015: 22 · 2014: 18 · 2013: 1
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Drug Delivery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of California, Davis
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- polymeric micelles, oral drug delivery, bioavailability enhancement, poorly water-soluble drugs, mucoadhesion, pH-responsive micelles, controlled drug release, P-glycoprotein inhibition, efflux pump inhibition, drug stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.